Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté (STeF-BFC)

Centre Hospitalier Universitaire de Besancon

Status: Completed

Conditions: Erythrocyte Transfusion for All Conditions

Study type: Observational

Funder types: Other

Identifiers

NCT02852993

P/2013/176

Details and patient eligibility

About

Red blood cell transfusion (RBC) is the main symptomatic treatment for severe anemia. RBC transfusion has proven its efficacy regarding mortality and morbidity, but it is not without side effects. The infectious side effects of transfusion are largely considered under control, non-infectious side effects are taking center stage. Seeking explanations for the beneficial and deleterious effects of RBC transfusions is necessary to ensure the safe and optimal use of this precious resource.

The investigators aim to study the impact of donor and RBC characteristics on patient survival.

Enrollment: 16,099 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged 18 and over
• Erythrocyte Transfusion between 2007 and 2011
• Performed at the University Hospital of Besançon or Dijon

Exclusion criteria

• Transfusion of any blood product prior to January 1st, 2007

Trial design

16,099 participants in 1 patient group

Transfused patients

Description:

A cohort of patients receiving erythrocyte transfusion for the first time at the CHU Besançon or CHU Dijon during the study period.